246 related articles for article (PubMed ID: 2196384)
1. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase.
Partin K; Kräusslich HG; Ehrlich L; Wimmer E; Carter C
J Virol; 1990 Aug; 64(8):3938-47. PubMed ID: 2196384
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain.
Zybarth G; Kräusslich HG; Partin K; Carter C
J Virol; 1994 Jan; 68(1):240-50. PubMed ID: 8254734
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
[TBL] [Abstract][Full Text] [Related]
4. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid.
Pettit SC; Simsic J; Loeb DD; Everitt L; Hutchison CA; Swanstrom R
J Biol Chem; 1991 Aug; 266(22):14539-47. PubMed ID: 1860860
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of a native substrate of the HIV-1 proteinase.
Partin K; Wimmer E; Carter C
Adv Exp Med Biol; 1991; 306():503-6. PubMed ID: 1667451
[TBL] [Abstract][Full Text] [Related]
6. Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease.
Margolin N; Heath W; Osborne E; Lai M; Vlahos C
Biochem Biophys Res Commun; 1990 Mar; 167(2):554-60. PubMed ID: 2182016
[TBL] [Abstract][Full Text] [Related]
7. In vitro processing of HIV-1 nucleocapsid protein by the viral proteinase: effects of amino acid substitutions at the scissile bond in the proximal zinc finger sequence.
Tözsér J; Shulenin S; Louis JM; Copeland TD; Oroszlan S
Biochemistry; 2004 Apr; 43(14):4304-12. PubMed ID: 15065874
[TBL] [Abstract][Full Text] [Related]
8. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
9. Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing.
Chiu HC; Wang FD; Chen YA; Wang CT
J Gen Virol; 2006 Jul; 87(Pt 7):2041-2046. PubMed ID: 16760407
[TBL] [Abstract][Full Text] [Related]
10. The Gag-Pol encoded proteinase of an avian retrovirus expressed in E. coli can produce a novel proteinase (PR + IleGly) that is two amino acids larger at its carboxy-terminal region than the major Gag proteinase (PR).
Brynda J; Fábry M; Horejsí M; Sedlácek J
Virology; 1995 Feb; 207(1):185-90. PubMed ID: 7871726
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly.
Yu XF; Dawson L; Tian CJ; Flexner C; Dettenhofer M
J Virol; 1998 Apr; 72(4):3412-7. PubMed ID: 9525672
[TBL] [Abstract][Full Text] [Related]
12. Deletion of sequences upstream of the proteinase improves the proteolytic processing of human immunodeficiency virus type 1.
Partin K; Zybarth G; Ehrlich L; DeCrombrugghe M; Wimmer E; Carter C
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4776-80. PubMed ID: 1647017
[TBL] [Abstract][Full Text] [Related]
13. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow C; Reardon IM; Howe WJ; DeCamp DL; Craik CS; Heinrikson RL
J Biol Chem; 1990 Aug; 265(24):14675-83. PubMed ID: 2201691
[TBL] [Abstract][Full Text] [Related]
14. Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.
Pichuantes S; Babé LM; Barr PJ; DeCamp DL; Craik CS
J Biol Chem; 1990 Aug; 265(23):13890-8. PubMed ID: 2199446
[TBL] [Abstract][Full Text] [Related]
15. Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.
Lee SK; Potempa M; Kolli M; Özen A; Schiffer CA; Swanstrom R
J Biol Chem; 2012 Apr; 287(16):13279-90. PubMed ID: 22334652
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.
Cameron CE; Grinde B; Jentoft J; Leis J; Weber IT; Copeland TD; Wlodawer A
J Biol Chem; 1992 Nov; 267(33):23735-41. PubMed ID: 1331099
[TBL] [Abstract][Full Text] [Related]
17. Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli.
Kräusslich HG; Schneider H; Zybarth G; Carter CA; Wimmer E
J Virol; 1988 Nov; 62(11):4393-7. PubMed ID: 3050149
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic cleavage at the Gag-Pol junction in avian leukosis virus: differences in vitro and in vivo.
Stewart L; Vogt VM
Virology; 1994 Oct; 204(1):45-59. PubMed ID: 7522375
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of HIV-1 proteinase by cerulenin.
Moelling K; Schulze T; Knoop MT; Kay J; Jupp R; Nicolaou G; Pearl LH
FEBS Lett; 1990 Feb; 261(2):373-7. PubMed ID: 1690152
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production.
Park J; Morrow CD
J Virol; 1991 Sep; 65(9):5111-7. PubMed ID: 1870215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]